708254-90-4 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 4-(2-[(4-cyanophenyl)amino]pyrimidin-4-ylamino)-3,5-dimethylbenzoate is used as a pharmaceutical compound for its potential biological or medicinal applications. The cyanophenyl group present in the compound is often associated with pharmaceutical activity, indicating its possible use in the development of new drugs or therapies.
Used in Agricultural Chemical Industry:
Ethyl 4-(2-[(4-cyanophenyl)amino]pyrimidin-4-ylamino)-3,5-dimethylbenzoate is also used as an agricultural chemical, given that pyrimidine derivatives are commonly found in this industry. Its specific application in agriculture would require further investigation and analysis to determine its potential use as a pesticide, herbicide, or other agricultural product.
Note: The specific properties and potential uses of ethyl 4-(2-[(4-cyanophenyl)amino]pyrimidin-4-ylamino)-3,5-dimethylbenzoate would likely require further investigation and analysis in a laboratory setting to fully understand its capabilities and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 708254-90-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,8,2,5 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 708254-90:
(8*7)+(7*0)+(6*8)+(5*2)+(4*5)+(3*4)+(2*9)+(1*0)=164
164 % 10 = 4
So 708254-90-4 is a valid CAS Registry Number.
708254-90-4Relevant academic research and scientific papers
Pharmaceutical compositions comprising a basic drug compound, a surfactant, and a physiologically tolerable water soluble acid
-
Page/Page column 55-56; 61, (2015/12/04)
The invention provides a novel pharmaceutical composition comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base characterized in that the acid respectively base:drug compound ratio is at least 1:1 by weight.
Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1
Guillemont, Jerome,Pasquier, Elisabeth,Palandjian, Patrice,Vernier, Daniel,Gaurrand, Sandrine,Lewi, Paul J.,Heeres, Jan,De Jonge, Marc R.,Koymans, Lucien M. H.,Daeyaert, Frits F. D.,Vinkers, Maarten H.,Arnold, Eddy,Das, Kalyan,Pauwels, Rudi,Andries, Koen,De Béthune, Marie-Pierre,Bettens, Eva,Hertogs, Kurt,Wigerinck, Piet,Timmerman, Philip,Janssen, Paul A. J.
, p. 2072 - 2079 (2007/10/03)
This paper reports the synthesis and the antiviral properties of new diarylpyrimidine (DAPY) compounds as nonnucleoside reverse transcriptase inhibitors (NNRTIs). The synthesis program around this new DAPY series was further optimized to produce compounds displaying improved activity against a panel of eight clinically relevant single and double mutant strains of human immunodeficiency virus type 1 (HIV-1).
